Honorary Professor

Janet Hardy

Email: 

Availability

Honorary Professor Janet Hardy is:
Available for supervision

Fields of research

Health Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Qualifications

  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Search Professor Janet Hardy’s works on UQ eSpace

255 works between 1987 and 2025
All (255) Journal Article (201) Book Chapter (26) Conference Publication (26) Book (1) Other Outputs (1)

241 - 255 of 255 works

1990

Journal Article

How nephrotoxic is carboplatin?

Hardy, J. R., Tan, S., Fryatt, I. and Wiltshaw, E. (1990). How nephrotoxic is carboplatin?. British Journal of Cancer, 61 (4), 644-644. doi: 10.1038/bjc.1990.143

How nephrotoxic is carboplatin?

1990

Journal Article

Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer

Hardy, JR, Powles, TJ, Judson, IR, Sinnett, HD, Ashley, SE, Coombes, RC and Ellin, CL (1990). Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer. European Journal of Cancer, 26 (7), 824-827. doi: 10.1016/0277-5379(90)90162-M

Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer

1990

Conference Publication

Dose intensity in ovarian-cancer

Hardy, J. R., Hryniuk, W. M. and Wiltshaw, E. (1990). Dose intensity in ovarian-cancer. 31st Annual Meeting of the British Association of Cancer Research and the 5th Annual Meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bjc.1990.324

Dose intensity in ovarian-cancer

1990

Conference Publication

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

Jones, A. L., Powles, T. J., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1990). Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac). 31st annual meeting of the British Association of Cancer Research and the 5th annual meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. BASINGSTOKE: STOCKTON PRESS. doi: 10.1038/bjc.1990.324

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

1989

Journal Article

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

Hardy, J. R., Noble, T. and Smith, I. E. (1989). Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. British Journal of Cancer, 60 (5), 764-766. doi: 10.1038/bjc.1989.355

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

1989

Journal Article

Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid

Olliff, Jfc, Hardy, JR, Williams, MP and Powles, TJ (1989). Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid. Clinical Radiology, 40 (6), 632-633. doi: 10.1016/S0009-9260(89)80329-0

Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid

1989

Journal Article

Chemoprevention of Breast-Cancer

Powles, TJ, Hardy, JR, Ashley, SE, Cosgrove, D, Davey, JB, Dowsett, M, McKinna, A, Nash, AG, Rundle, SK, Sinnett, HD, Tillyer, CR and Treleaven, JG (1989). Chemoprevention of Breast-Cancer. Breast Cancer Research and Treatment, 14 (1), 23-31. doi: 10.1007/BF01805972

Chemoprevention of Breast-Cancer

1989

Journal Article

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

Powles, T. J., Hardy, J. R., Ashley, S. E., Farrington, G. M., Cosgrove, D., Davey, J. B., Dowsett, M., McKinna, J. A., Nash, A. G., Sinnett, H. D., Tillyer, C. R. and Treleaven, J. G. (1989). A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. British Journal of Cancer, 60 (1), 126-131. doi: 10.1038/bjc.1989.235

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

1989

Journal Article

Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy

Hardy, JR and Harvey, VJ (1989). Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy. Gynecologic Oncology, 33 (3), 296-300. doi: 10.1016/0090-8258(89)90515-5

Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy

1989

Conference Publication

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

Evans, PC, Hardy, JR, Paxton, JW, Harvey, VJ and Baguley, BC (1989). The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study. WELLINGTON: NEW ZEALAND MED ASSN.

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

1989

Conference Publication

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

Lonning, PE, Dowsett, M, Jacobs, S, Schem, B, Hardy, J and Powles, TJ (1989). Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women. 9th International Symp of the Journal of Steroid Biochemistry : Recent Advances in Steroid Biochemistry, Las Palmas Gran Canaria Spain, May 28-31, 1989. doi: 10.1016/0022-4731(89)90143-X

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

1989

Journal Article

The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit

Paxton, JW, Evans, PC and Hardy, JR (1989). The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit. Cancer Chemotherapy and Pharmacology, 23 (5), 291-295. doi: 10.1007/BF00292406

The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit

1988

Journal Article

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

Hardy, JR, Harvey, VJ, Paxton, JW, Evans, P, Smith, S, Grove, W, Grillolopez, AJ and Baguley, BC (1988). Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921). Cancer Research, 48 (22), 6593-6596.

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

1988

Journal Article

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

Paxton, JW, Hardy, JR, Evans, PC, Harvey, VJ and Baguley, BC (1988). The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial. Cancer Chemotherapy and Pharmacology, 22 (3), 235-240. doi: 10.1007/BF00273417

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

1987

Journal Article

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy

Hardy, JR, Maclean, GD, Foote, GA and Harvey, VJ (1987). The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 27 (2), 146-149. doi: 10.1111/j.1479-828X.1987.tb00967.x

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy

Current funding

  • 2021 - 2026
    Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer
    NHMRC MRFF EPCDR Medicinal Cannabis
    Open grant

Past funding

  • 2018 - 2023
    Medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer
    NHMRC MRFF - Lifting Clinical Trials Registries Capacity
    Open grant
  • 2017 - 2020
    Talking about death: A study into palliative care communication
    Mater Misericordiae Ltd
    Open grant
  • 2010 - 2016
    A randomised controlled trial of aetiology based antiemetic guidelines for reducing nausea in advanced cancer patients (NHMRC Project Grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2010 - 2012
    n-of-1 trials of pilocarpine vs placebo for dry mouth in palliative care patients
    Cancer Council Queensland
    Open grant
  • 2009 - 2012
    Using n-of 1 trials to determine the effectiveness of paracetamol in advanced cancer patients on opioids
    NHMRC Palliative Care Research Program
    Open grant
  • 2008 - 2012
    Using single patient trials to determine the effectiveness of psychostimulants in end stage fatigue in cancer patients.
    NHMRC Palliative Care Research Program
    Open grant

Availability

Honorary Professor Janet Hardy is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Enquiries

For media enquiries about Honorary Professor Janet Hardy's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au